Zhang YW - Search Results

1

Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.

Zhang YW, Su Y, Volpert OV, Vande Woude GF. Zhang YW, et al. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12718-23. doi: 10.1073/pnas.2135113100. Epub 2003 Oct 10. Proc Natl Acad Sci U S A. 2003. PMID: 14555767 Free PMC article.

2

Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis.

Zhang YW, Wang LM, Jove R, Vande Woude GF. Zhang YW, et al. Oncogene. 2002 Jan 10;21(2):217-26. doi: 10.1038/sj.onc.1205004. Oncogene. 2002. PMID: 11803465

3

Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor/scatter factor.

Zhang YW, Su Y, Lanning N, Gustafson M, Shinomiya N, Zhao P, Cao B, Tsarfaty G, Wang LM, Hay R, Vande Woude GF. Zhang YW, et al. Oncogene. 2005 Jan 6;24(1):101-6. doi: 10.1038/sj.onc.1208181. Oncogene. 2005. PMID: 15531925

4

Targeted disruption of Mig-6 in the mouse genome leads to early onset degenerative joint disease.

Zhang YW, Su Y, Lanning N, Swiatek PJ, Bronson RT, Sigler R, Martin RW, Vande Woude GF. Zhang YW, et al. Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11740-5. doi: 10.1073/pnas.0505171102. Epub 2005 Aug 8. Proc Natl Acad Sci U S A. 2005. PMID: 16087873 Free PMC article.

5

Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma.

Gao CF, Xie Q, Zhang YW, Su Y, Zhao P, Cao B, Furge K, Sun J, Rex K, Osgood T, Coxon A, Burgess TL, Vande Woude GF. Gao CF, et al. Among authors: zhang yw. Mol Cancer Ther. 2009 Oct;8(10):2803-10. doi: 10.1158/1535-7163.MCT-09-0125. Mol Cancer Ther. 2009. PMID: 19825800

6

MET kinase inhibitor SGX523 synergizes with epidermal growth factor receptor inhibitor erlotinib in a hepatocyte growth factor-dependent fashion to suppress carcinoma growth.

Zhang YW, Staal B, Essenburg C, Su Y, Kang L, West R, Kaufman D, Dekoning T, Eagleson B, Buchanan SG, Vande Woude GF. Zhang YW, et al. Cancer Res. 2010 Sep 1;70(17):6880-90. doi: 10.1158/0008-5472.CAN-10-0898. Epub 2010 Jul 19. Cancer Res. 2010. PMID: 20643778

7

HGF/SF-met signaling in the control of branching morphogenesis and invasion.

Zhang YW, Vande Woude GF. Zhang YW, et al. J Cell Biochem. 2003 Feb 1;88(2):408-17. doi: 10.1002/jcb.10358. J Cell Biochem. 2003. PMID: 12520544 Review.

8

Met decoys: will cancer take the bait?

Zhang YW, Graveel C, Shinomiya N, Vande Woude GF. Zhang YW, et al. Cancer Cell. 2004 Jul;6(1):5-6. doi: 10.1016/j.ccr.2004.07.003. Cancer Cell. 2004. PMID: 15261136 Free article.

9

RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival.

Shinomiya N, Gao CF, Xie Q, Gustafson M, Waters DJ, Zhang YW, Vande Woude GF. Shinomiya N, et al. Among authors: zhang yw. Cancer Res. 2004 Nov 1;64(21):7962-70. doi: 10.1158/0008-5472.CAN-04-1043. Cancer Res. 2004. PMID: 15520203

10

Mig-6, signal transduction, stress response and cancer.

Zhang YW, Vande Woude GF. Zhang YW, et al. Cell Cycle. 2007 Mar 1;6(5):507-13. doi: 10.4161/cc.6.5.3928. Epub 2007 Mar 31. Cell Cycle. 2007. PMID: 17351343 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,610 results

Search Page